These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23783103)

  • 41. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
    Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
    Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma.
    Sheu SY; Vogel E; Worm K; Grabellus F; Schwertheim S; Schmid KW
    Histopathology; 2010 Apr; 56(5):632-40. PubMed ID: 20459574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.
    Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y
    Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
    Dettmer M; Vogetseder A; Durso MB; Moch H; Komminoth P; Perren A; Nikiforov YE; Nikiforova MN
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E1-7. PubMed ID: 23150679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study.
    Qiu ZL; Shen CT; Song HJ; Wei WJ; Luo QY
    Nucl Med Biol; 2015 May; 42(5):499-504. PubMed ID: 25682061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-150-5p affects cell proliferation, apoptosis, and EMT by regulation of the BRAF
    Yan R; Yang T; Zhai H; Zhou Z; Gao L; Li Y
    J Cell Biochem; 2018 Nov; 119(11):8763-8772. PubMed ID: 30126001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional analysis of a novel, thyroglobulin-embedded microRNA gene deregulated in papillary thyroid carcinoma.
    Kolanowska M; Wójcicka A; Kubiak A; Świerniak M; Kotlarek M; Maciąg M; Gaj P; Koperski Ł; Górnicka B; Jażdżewski K
    Sci Rep; 2017 Aug; 7(1):9942. PubMed ID: 28855631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miRNA profiling, detection of BRAF V600E mutation and RET-PTC1 translocation in patients from Novosibirsk oblast (Russia) with different types of thyroid tumors.
    Titov SE; Ivanov MK; Karpinskaya EV; Tsivlikova EV; Shevchenko SP; Veryaskina YA; Akhmerova LG; Poloz TL; Klimova OA; Gulyaeva LF; Zhimulev IF; Kolesnikov NN
    BMC Cancer; 2016 Mar; 16():201. PubMed ID: 26960768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses.
    Graham ME; Hart RD; Douglas S; Makki FM; Pinto D; Butler AL; Bullock M; Rigby MH; Trites JR; Taylor SM; Singh R
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):33. PubMed ID: 26341226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.
    Li M; Song Q; Li H; Lou Y; Wang L
    PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.
    Minna E; Romeo P; De Cecco L; Dugo M; Cassinelli G; Pilotti S; Degl'Innocenti D; Lanzi C; Casalini P; Pierotti MA; Greco A; Borrello MG
    Oncotarget; 2014 May; 5(9):2513-28. PubMed ID: 24810336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling.
    Akyay OZ; Gov E; Kenar H; Arga KY; Selek A; Tarkun İ; Canturk Z; Cetinarslan B; Gurbuz Y; Sahin B
    OMICS; 2020 Mar; 24(3):148-159. PubMed ID: 32073999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.
    Chou CK; Chi SY; Huang CH; Chou FF; Huang CC; Liu RT; Kang HY
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4357-4366. PubMed ID: 27533309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
    Dong G; Zhang R; Xu J; Guo Y
    Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
    Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
    Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
    Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG
    Oncotarget; 2016 Mar; 7(11):12731-47. PubMed ID: 26871295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas.
    Zhou YL; Liu C; Dai XX; Zhang XH; Wang OC
    Med Oncol; 2012 Dec; 29(5):3360-6. PubMed ID: 22855362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
    Liu L; Wang J; Li X; Ma J; Shi C; Zhu H; Xi Q; Zhang J; Zhao X; Gu M
    Biochem Biophys Res Commun; 2015 Feb; 457(4):621-6. PubMed ID: 25603050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222.
    Lee JC; Zhao JT; Gundara J; Serpell J; Bach LA; Sidhu S
    J Surg Res; 2015 Jun; 196(1):39-48. PubMed ID: 25819770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a.
    Long M; Zhu Y; Chen Z; Lin S; Peng X; Luo D; Li H; Tan L
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.